DTI Laboratories, Inc., (DTIL)is considered a leader in hemoglobin A1c testing including: detection of abnormal hemoglobin variants (such as Hb S, C and Fetal hemoglobin). DTIL developed the first FDA approved finger-stick (capillary) A1c collection test kit in 1998. In 2002 the AccuBase A1c kit was FDA approved for OTC use. In addition to being a leading company in A1c testing at-home, the AccuBase HPLC-IE technology kit has supported major clinical trials for many years. DTIL continues to support over a dozen major Universities (specific references upon request) in areas of studies for diabetes, pre-diabetes, clinical out comes, research and behavioral neuroscience. Publication references upon request.
DTIL has developed and published a series of diabetes education titles, in an effort to improve the quality of clinical care and quality of life for individuals with all forms of diabetes. Plans are to update education materials on a regular basis.
DTIL is full-service organization dedicated to individuals with all forms of diabetes. Our highly experienced staff of Doctors, Technicians, Laboratory Personnel, Certified Diabetes Educator (CDE), research scientist believe in working with our patients.
and clients to improve their diabetes control and care. We work together to serve the needs of the diabetes community.
For further information please call: 1.888.872.2443.
Copyright © 2023 DTI Laboratories, Inc - All Rights Reserved.